Elanco
Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
DitchCarbon Score
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elanco's score of 54 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elanco's reported carbon emissions
In 2023, Elanco reported total carbon emissions of approximately 1,432,209,000 kg CO2e. This figure includes Scope 1 emissions of about 146,978,000 kg CO2e, Scope 2 emissions of approximately 180,773,000 kg CO2e (market-based), and Scope 3 emissions of around 655,353,000 kg CO2e. The combined Scope 1 and 2 emissions totalled about 432,209,000 kg CO2e. Elanco has set ambitious climate commitments, aiming for net zero Scope 1 and 2 greenhouse gas emissions for its Hook office by 2030. Additionally, the company is committed to helping its customers avoid approximately 21 million metric tons of GHG emissions by 2030, using 2020 as the base year. This commitment is part of a broader strategy to purchase renewable electricity equal to 100% of its electricity consumption by 2030. The company is also aligned with the Science Based Targets initiative (SBTi), committing to long-term net zero targets across all scopes by 2050. Elanco's U.K. and Ireland affiliate has set a goal to eliminate internal combustion engine vehicles from its fleet by 2030, further demonstrating its commitment to reducing emissions. Overall, Elanco's emissions data and climate commitments reflect a proactive approach to sustainability and carbon reduction, positioning the company as a responsible player in the animal health industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
